Stephen Willey
Stock Analyst at Stifel Nicolaus
(4.24)
# 1,306
Out of 5,036 analysts
619
Total ratings
42.5%
Success rate
7.2%
Average return
Main Sectors:
Stocks Rated by Stephen Willey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OABI OmniAb | Reiterated: Buy | $9 | $4.56 | +97.37% | 12 | Oct 7, 2026 | |
| CBIO Crescent Biopharma | Reiterated: Buy | $28 | $13.49 | +107.56% | 19 | Oct 6, 2026 | |
| CGEN Compugen | Reiterated: Buy | $4 | $2.15 | +86.05% | 11 | Oct 6, 2026 | |
| INCY Incyte | Reiterated: Buy | $145 → $157 | $113.44 | +38.40% | 41 | Oct 5, 2026 | |
| NKTX Nkarta | Reiterated: Buy | $10 | $2.27 | +340.53% | 27 | Sep 28, 2026 | |
| VOR Vor Biopharma | Reiterated: Buy | $40 | $18.78 | +112.99% | 25 | Sep 28, 2026 | |
| CMPX Compass Therapeutics | Reiterated: Buy | n/a | $1.02 | - | 15 | Sep 22, 2026 | |
| EXEL Exelixis | Reiterated: Hold | n/a | $58.44 | - | 56 | Sep 11, 2026 | |
| LYEL Lyell Immunopharma | Reiterated: Buy | $36 | $8.56 | +320.56% | 3 | Sep 11, 2026 | |
| PYXS Pyxis Oncology | Reiterated: Buy | $8 → $7 | $2.01 | +248.26% | 7 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $9.82 | +124.03% | 2 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $175 → $150 | $65.78 | +128.03% | 11 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 | $3.55 | +12.68% | 36 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $17.03 | +134.88% | 10 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $46 → $45 | $16.42 | +174.06% | 15 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 | $17.92 | +95.31% | 6 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $46 | $26.53 | +73.39% | 34 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $9 | $12.83 | -29.85% | 19 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $111 | $61.18 | +81.43% | 11 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $200 | $101.74 | +96.58% | 30 | Jul 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $34 → $40 | $22.73 | +75.98% | 30 | Jul 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $5.08 | +234.65% | 6 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $7.5 | $2.81 | +166.90% | 17 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $28 | $7.04 | n/a | 1 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $25 → $20 | $3.60 | n/a | 12 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $1.20 | n/a | 16 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $22.51 | n/a | 15 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7 → $6 | $1.27 | n/a | 17 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9 → $5 | $0.7286 | n/a | 4 | May 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 → $5 | $4.36 | n/a | 6 | May 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 → $1 | $1.16 | n/a | 15 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $27 | $1.17 | n/a | 4 | Mar 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 | $1.76 | n/a | 11 | Mar 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 → $21 | $36.41 | n/a | 5 | Mar 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $160 | $2.59 | n/a | 1 | Mar 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $95 → $125 | $224.41 | n/a | 6 | Aug 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $109 → $114 | $55.20 | n/a | 14 | Aug 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $55 → $48 | $44.16 | n/a | 13 | Aug 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $17 → $16 | $21.06 | n/a | 13 | Apr 27, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $13 → $2.5 | $0.000001 | n/a | 3 | Sep 26, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $26 | $14.32 | n/a | 2 | Apr 4, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $1.10 | n/a | 1 | Feb 2, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 | $6.68 | n/a | 1 | Dec 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $200 | $231.19 | n/a | 1 | May 31, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $7.24 | n/a | 5 | Dec 2, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $101 | - | n/a | 5 | Mar 31, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $31 → $26 | $4.29 | n/a | 3 | Nov 7, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 → $7 | $47.99 | n/a | 2 | Apr 8, 2013 |
OmniAb
Oct 7, 2026
Reiterated: Buy
Price Target: $9
Current: $4.56
Upside: +97.37%
Crescent Biopharma
Oct 6, 2026
Reiterated: Buy
Price Target: $28
Current: $13.49
Upside: +107.56%
Compugen
Oct 6, 2026
Reiterated: Buy
Price Target: $4
Current: $2.15
Upside: +86.05%
Incyte
Oct 5, 2026
Reiterated: Buy
Price Target: $145 → $157
Current: $113.44
Upside: +38.40%
Nkarta
Sep 28, 2026
Reiterated: Buy
Price Target: $10
Current: $2.27
Upside: +340.53%
Vor Biopharma
Sep 28, 2026
Reiterated: Buy
Price Target: $40
Current: $18.78
Upside: +112.99%
Compass Therapeutics
Sep 22, 2026
Reiterated: Buy
Price Target: n/a
Current: $1.02
Upside: -
Exelixis
Sep 11, 2026
Reiterated: Hold
Price Target: n/a
Current: $58.44
Upside: -
Lyell Immunopharma
Sep 11, 2026
Reiterated: Buy
Price Target: $36
Current: $8.56
Upside: +320.56%
Pyxis Oncology
Aug 17, 2026
Reiterated: Buy
Price Target: $8 → $7
Current: $2.01
Upside: +248.26%
Aug 14, 2026
Reiterated: Buy
Price Target: $22
Current: $9.82
Upside: +124.03%
Aug 14, 2026
Reiterated: Buy
Price Target: $175 → $150
Current: $65.78
Upside: +128.03%
Aug 14, 2026
Reiterated: Hold
Price Target: $4
Current: $3.55
Upside: +12.68%
Aug 14, 2026
Reiterated: Buy
Price Target: $40
Current: $17.03
Upside: +134.88%
Aug 13, 2026
Reiterated: Buy
Price Target: $46 → $45
Current: $16.42
Upside: +174.06%
Aug 11, 2026
Reiterated: Buy
Price Target: $35
Current: $17.92
Upside: +95.31%
Aug 11, 2026
Reiterated: Buy
Price Target: $46
Current: $26.53
Upside: +73.39%
Aug 6, 2026
Reiterated: Buy
Price Target: $8 → $9
Current: $12.83
Upside: -29.85%
Jul 31, 2026
Reiterated: Buy
Price Target: $111
Current: $61.18
Upside: +81.43%
Jul 17, 2026
Reiterated: Buy
Price Target: $200
Current: $101.74
Upside: +96.58%
Jul 10, 2026
Rated: Buy
Price Target: $34 → $40
Current: $22.73
Upside: +75.98%
Mar 18, 2026
Reiterated: Buy
Price Target: $17
Current: $5.08
Upside: +234.65%
Nov 5, 2025
Reiterated: Buy
Price Target: $9 → $7.5
Current: $2.81
Upside: +166.90%
Jun 24, 2025
Initiated Coverage: Buy
Price Target: $28
Current: $7.04
Upside: n/a
May 13, 2025
Reiterated: Hold
Price Target: $25 → $20
Current: $3.60
Upside: n/a
Mar 12, 2025
Reiterated: Buy
Price Target: $4
Current: $1.20
Upside: n/a
Nov 15, 2024
Reiterated: Buy
Price Target: $4
Current: $22.51
Upside: n/a
May 14, 2024
Reiterated: Hold
Price Target: $7 → $6
Current: $1.27
Upside: n/a
May 13, 2022
Reiterated: Hold
Price Target: $9 → $5
Current: $0.7286
Upside: n/a
May 13, 2022
Reiterated: Hold
Price Target: $6 → $5
Current: $4.36
Upside: n/a
May 11, 2022
Reiterated: Hold
Price Target: $3 → $1
Current: $1.16
Upside: n/a
Mar 12, 2021
Reiterated: Buy
Price Target: $25 → $27
Current: $1.17
Upside: n/a
Mar 11, 2021
Reiterated: Hold
Price Target: $6
Current: $1.76
Upside: n/a
Mar 29, 2019
Reiterated: Buy
Price Target: $18 → $21
Current: $36.41
Upside: n/a
Mar 14, 2019
Reiterated: Hold
Price Target: $160
Current: $2.59
Upside: n/a
Aug 6, 2018
Upgraded: Buy
Price Target: $95 → $125
Current: $224.41
Upside: n/a
Aug 6, 2018
Reiterated: Buy
Price Target: $109 → $114
Current: $55.20
Upside: n/a
Aug 6, 2018
Reiterated: Hold
Price Target: $55 → $48
Current: $44.16
Upside: n/a
Apr 27, 2018
Reiterated: Hold
Price Target: $17 → $16
Current: $21.06
Upside: n/a
Sep 26, 2017
Downgraded: Hold
Price Target: $13 → $2.5
Current: $0.000001
Upside: n/a
Apr 4, 2017
Reiterated: Buy
Price Target: $20 → $26
Current: $14.32
Upside: n/a
Feb 2, 2017
Reiterated: Buy
Price Target: $24
Current: $1.10
Upside: n/a
Dec 2, 2016
Reiterated: Buy
Price Target: $23
Current: $6.68
Upside: n/a
May 31, 2016
Reiterated: Buy
Price Target: $200
Current: $231.19
Upside: n/a
Dec 2, 2015
Downgraded: Hold
Price Target: n/a
Current: $7.24
Upside: n/a
Mar 31, 2015
Downgraded: Hold
Price Target: $101
Current: -
Upside: n/a
Nov 7, 2014
Reiterated: Buy
Price Target: $31 → $26
Current: $4.29
Upside: n/a
Apr 8, 2013
Reiterated: Buy
Price Target: $11 → $7
Current: $47.99
Upside: n/a